Gross Margin
17.93%vs Specialty Chemicals peers Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 15.49%.Updated Aug 20, 2026Profit Margin
6.95%vs Specialty Chemicals peers Updated Aug 20, 2026Operating Margin
12.05%vs Specialty Chemicals peers Updated Aug 20, 2026Return on Assets (TTM)
4.98%vs Specialty Chemicals peers Updated Aug 20, 2026Return on Equity (TTM)
11.04%vs Specialty Chemicals peers Updated Aug 20, 2026Revenue (TTM)
9.20BTWD288.64M · vs all stocks (USD) Updated Aug 20, 2026Revenue per Share (TTM)
76.07TWDUpdated Aug 20, 2026Quarterly Revenue Growth
116.50%vs Specialty Chemicals peers Updated Aug 20, 2026Gross Profit (TTM)
1.42BTWD44.71M · vs all stocks (USD) Updated Aug 20, 2026EBITDA (TTM)
1.07BTWD33.57M · vs all stocks (USD) Updated Aug 20, 2026Net Income (TTM)
639.36MTWD20.06M · vs all stocks (USD) Updated Aug 20, 2026Quarterly Earnings Growth (YoY)
3629.40%vs Specialty Chemicals peers Updated Aug 20, 2026Operating Cash Flow (TTM)
-252.95MTWD-7.94M · vs all stocks (USD) Updated Aug 20, 2026Levered Free Cash Flow (TTM)
-1.46BTWD-45.89M · vs all stocks (USD) Updated Aug 20, 2026Trailing Annual Dividend Rate
1.0000TWDUpdated Aug 20, 2026Trailing Annual Dividend Yield
1.19%Updated Aug 20, 20265-Year Average Dividend Yield
2.14%Updated Aug 20, 2026Payout Ratio
21.10%vs Specialty Chemicals peers Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 33.33%.Updated Aug 20, 2026Minority Interest (Equity)
957.46MTWDFY2025 · Dec 31, 2025Revenue
6.19BTWDFY2025 · Dec 31, 2025Cost of Goods Sold
5.34BTWDFY2025 · Dec 31, 2025Gross Profit
848.66MTWDFY2025 · Dec 31, 2025Operating Income
440.09MTWD13.81M · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
225.69MTWDFY2025 · Dec 31, 2025Income Tax Expense
71.74MTWDFY2025 · Dec 31, 2025Net Income
153.96MTWDFY2025 · Dec 31, 2025EBIT
324.14MTWDFY2025 · Dec 31, 2025EBITDA (Income Statement)
680.61MTWDFY2025 · Dec 31, 2025Research & Development
18.91MTWDFY2025 · Dec 31, 2025Selling, General & Administrative
389.65MTWDFY2025 · Dec 31, 2025Non-operating Interest Income
46.37MTWDFY2025 · Dec 31, 2025Non-operating Interest Expense
98.45MTWDFY2025 · Dec 31, 2025Minority Interests (P&L)
30.35MTWDFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00TWDFY2025 · Dec 31, 2025Operating Cash Flow
-793.46MTWDFY2025 · Dec 31, 2025Free Cash Flow
-1.73BTWDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
3.32BTWDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
225.69MTWDFY2025 · Dec 31, 2025Stock-based Compensation
8.40MTWDFY2025 · Dec 31, 2025Other Non-cash Items
54.70MTWDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-113.26MTWDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-969.00MTWDFY2025 · Dec 31, 2025Capital Expenditures
-935.14MTWDFY2025 · Dec 31, 2025Purchase of Investments
-262.03MTWDFY2025 · Dec 31, 2025Sale of Investments
0.00TWDFY2025 · Dec 31, 2025Other Investing Activity
42.70MTWDFY2025 · Dec 31, 2025Net Investing Cash Flow
-1.15BTWDFY2025 · Dec 31, 2025Long-term Debt Issuance
1.74BTWDFY2025 · Dec 31, 2025Long-term Debt Payments
-498.97MTWDFY2025 · Dec 31, 2025Net Short-term Debt Issuance
1.01BTWDFY2025 · Dec 31, 2025Common Dividends Paid
-112.08MTWDFY2025 · Dec 31, 2025Other Financing Charges
-36.87MTWDFY2025 · Dec 31, 2025Net Financing Cash Flow
2.14BTWDFY2025 · Dec 31, 2025